We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.
Chapters
Intro - 0:59
Maintenance - 3:54
Commercial prospects - 18:16
Crohn's - 21:43
Buyout prospects - 27:03
How did Wall Street analysts miss this? - 41:31
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
​
​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.
.png){kind=logo}
